[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367988-105":59,"doc-detail-367988-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pancreatic-cancer-in-2025-have-we-found-a-solution","Pancreatic cancer in 2025: Have we found a solution?","","Pancreatic cancer remains among the neoplasms with the poorest prognosis due to late presentation that often eliminates curative surgery, aggressive tumor biology, and resistance to antiblastic drugs. This invited review summarizes advances from recent years following the authors’ previous work, focusing on progress across prevention and early detection, improved molecular understanding, and more effective systemic therapies. It also highlights the role of artificial intelligence in accelerating research and improving clinical outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pancreatic-cancer-in-2025-have-we-found-a-solution/367988/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pancreatic-cancer-in-2025-have-we-found-a-solution/367988.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does pancreatic cancer still have a poor prognosis?","Question",{"text":112,"@type":113},"Late presentation at an unresectable or metastatic stage prevents surgery, while aggressive biology and resistance to antiblastic drugs worsen outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What areas of progress are discussed in the review?",{"text":117,"@type":113},"The review covers improved prevention and early detection, refined molecular understanding, identification of more effective systemic therapies, and better quality of life and surgical outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"How is artificial intelligence addressed in the article?",{"text":121,"@type":113},"The review emphasizes the technological aspect of artificial intelligence as a key area looking forward to improvements in this disease.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367988,1792168693,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","| W | J | G | World Journal of\u003Cbr>Gastroenterology |\n| --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Gastroenterol 2025 November 21; 31(43): 111433  \nDOI: 10.3748/wjg.v31.i43.111433 ISSN 1007-9327 (print) ISSN 2219-2840 (online)  \nREVIEW  \nPancreatic cancer in 2025: Have we found a solution?  \nValeria Tonini, Manuel Zanni  \nSpecialty type: Gastroenterology and hepatology  \nProvenance and peer review:  \nInvited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s classification Scientific Quality: Grade B, Grade B, Grade B  \nNovelty: Grade B, Grade B, Grade B  \nCreativity or Innovation: Grade B, Grade B, Grade B  \nScientific Significance: Grade B, Grade B, Grade B  \nP-Reviewer: Chen YZ, PhD, Postdoctoral Fellow, China; Li F, MD, Assistant Professor, China  \nReceived: June 30, 2025  \nRevised: July 28, 2025  \nAccepted: October 9, 2025  \nPublished online: November 21, 2025  \nProcessing time: 144 Days and 7.4 Hours  \nValeria Tonini, Manuel Zanni, Department of Medical and Surgical Sciences, University of Bologna, Bologna 40138, Emilia-Romagna, Italy  \nCo-first authors: Valeria Tonini and Manuel Zanni.  \nCorresponding author: Valeria Tonini, MD, Adjunct Associate Professor, Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, Bologna 40138, Emilia-Romagna, [Italy.](Italy. valeria.tonini@unibo.it)[ valeria.tonini@unibo.it](Italy. valeria.tonini@unibo.it)  \nAbstract  \nPancreatic cancer is still one of the neoplasms with the worst prognosis. Late presentation at an unresectable or metastatic stage precluding surgery, aggressive biology, and resistance to antiblastic drugs make this disease a formidable foe. The authors, following the path already traced by the previous review, investigate and summarize the breakthroughs of recent years concerning this lethal disease. Areas of progress include improving prevention and early detection strategies, refining molecular understanding of pancreatic cancer, identifying more effective systemic therapies, and improving quality of life and surgical outcomes. No less important is the technological aspect that looks primarily at artificial intelligence.  \nKey Words: Pancreatic cancer; Early diagnosis; Therapeutic development; Precision medicine; Target therapy; Immunotherapy; Pancreatic surgery  \n©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.  \nCore Tip: Pancreatic cancer is still one of the neoplasms with the worst prognosis. Late presentation at an unresectable or metastatic stage precluding surgery, aggressive biology, and resistance to antiblastic drugs make this disease a fearsome challenge. This review aims to investigate new strategies for early diagnosis and new therapeutic hopes for improving the still tragic outcomes.  \nCitation: Tonini V, Zanni M. Pancreatic cancer in 2025: Have we found a solution? World JGastroenterol 2025; 31(43): 111433  \nURL: [https://www.wjgnet.com/1007-9327/full/v31/i43/111433.htm](https://www.wjgnet.com/1007-9327/full/v31/i43/111433.htm)  \nDOI: [https://dx.doi.org/10.3748/wjg.v31.i43.111433](https://dx.doi.org/10.3748/wjg.v31.i43.111433)  \n WJG  [https://www.wjgnet.com](https://www.wjgnet.com) 1 November 21, 2025  Volume 31  Issue 43   \nINTRODUCTION  \nPancreatic cancer is one of the deadliest malignancies and poses a significant global health challenge. It ranks 12th in incidence and 6th in cumulative mortality[1] . In the Western world it is the third leading cause of cancer death [2] . Despite advances in healthcare, survival rates have seen little improvement [3] . Retroperitoneal localization, nonspecific symptoms in early stages, and its aggressive biology contribute to the high percentage of patients (51%) presenting with metastatic disease at diagnosis. Additionally, the limited treatment options is due to its desmoplastic and chemoresistant nature [4] . Pancreatic ductal adenoc","cbCaimjRUYEghrxR","https://ap.wps.com/l/cbCaimjRUYEghrxR","pdf",742571,26,"English","# Introduction\n# Epidemiology","[{\"question\":\"Why does pancreatic cancer still have a poor prognosis?\",\"answer\":\"Late presentation at an unresectable or metastatic stage prevents surgery, while aggressive biology and resistance to antiblastic drugs worsen outcomes.\"},{\"question\":\"What areas of progress are discussed in the review?\",\"answer\":\"The review covers improved prevention and early detection, refined molecular understanding, identification of more effective systemic therapies, and better quality of life and surgical outcomes.\"},{\"question\":\"How is artificial intelligence addressed in the article?\",\"answer\":\"The review emphasizes the technological aspect of artificial intelligence as a key area looking forward to improvements in this disease.\"}]","Pancreatic cancer in 2025: Have we found a solution? | PDF",1790174200,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f5cedaadb8fedfa346f93827978ec3f.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a65acfda6ead95572d6a89a09a3599c8.webp",982,1389,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ab663155ca6ad12efb6941b4ec83aac.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c56c8b2594fbccd6b12babb6e0c43b06.webp",980,1386]